273 related articles for article (PubMed ID: 27279617)
21. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
[TBL] [Abstract][Full Text] [Related]
22. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
[TBL] [Abstract][Full Text] [Related]
23. Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD
J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921
[TBL] [Abstract][Full Text] [Related]
24. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
25. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.
Crawford H; Lumm W; Leslie A; Schaefer M; Boeras D; Prado JG; Tang J; Farmer P; Ndung'u T; Lakhi S; Gilmour J; Goepfert P; Walker BD; Kaslow R; Mulenga J; Allen S; Goulder PJ; Hunter E
J Exp Med; 2009 Apr; 206(4):909-21. PubMed ID: 19307327
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
[TBL] [Abstract][Full Text] [Related]
27. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.
Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM
J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731
[TBL] [Abstract][Full Text] [Related]
28. HLA-associated immune pressure on Gag protein in CRF01_AE-infected individuals and its association with plasma viral load.
Gesprasert G; Wichukchinda N; Mori M; Shiino T; Auwanit W; Sriwanthana B; Pathipvanich P; Sawanpanyalert P; Miura T; Auewarakul P; Thitithanyanont A; Ariyoshi K
PLoS One; 2010 Jun; 5(6):e11179. PubMed ID: 20567513
[TBL] [Abstract][Full Text] [Related]
29. Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells.
Hulme AE; Kelley Z; Okocha EA; Hope TJ
J Virol; 2015 Jan; 89(1):643-51. PubMed ID: 25339776
[TBL] [Abstract][Full Text] [Related]
30. A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1.
Ammaranond P; Zaunders J; Satchell C; van Bockel D; Cooper DA; Kelleher AD
AIDS Res Hum Retroviruses; 2005 May; 21(5):395-7. PubMed ID: 15929701
[TBL] [Abstract][Full Text] [Related]
31. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.
Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD
J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253
[TBL] [Abstract][Full Text] [Related]
32. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
[TBL] [Abstract][Full Text] [Related]
33. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
[TBL] [Abstract][Full Text] [Related]
34. The hypervariable HIV-1 capsid protein residues comprise HLA-driven CD8+ T-cell escape mutations and covarying HLA-independent polymorphisms.
Crawford H; Matthews PC; Schaefer M; Carlson JM; Leslie A; Kilembe W; Allen S; Ndung'u T; Heckerman D; Hunter E; Goulder PJ
J Virol; 2011 Feb; 85(3):1384-90. PubMed ID: 21106744
[TBL] [Abstract][Full Text] [Related]
35. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.
Song H; Pavlicek JW; Cai F; Bhattacharya T; Li H; Iyer SS; Bar KJ; Decker JM; Goonetilleke N; Liu MK; Berg A; Hora B; Drinker MS; Eudailey J; Pickeral J; Moody MA; Ferrari G; McMichael A; Perelson AS; Shaw GM; Hahn BH; Haynes BF; Gao F
Retrovirology; 2012 Oct; 9():89. PubMed ID: 23110705
[TBL] [Abstract][Full Text] [Related]
36. Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation.
Liu D; Zuo T; Hora B; Song H; Kong W; Yu X; Goonetilleke N; Bhattacharya T; Perelson AS; Haynes BF; McMichael AJ; Gao F
Retrovirology; 2014 Nov; 11():101. PubMed ID: 25407514
[TBL] [Abstract][Full Text] [Related]
37. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.
Klenerman P; Rowland-Jones S; McAdam S; Edwards J; Daenke S; Lalloo D; Köppe B; Rosenberg W; Boyd D; Edwards A
Nature; 1994 Jun; 369(6479):403-7. PubMed ID: 7515165
[TBL] [Abstract][Full Text] [Related]
39. Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints.
Payne RP; Branch S; Kløverpris H; Matthews PC; Koofhethile CK; Strong T; Adland E; Leitman E; Frater J; Ndung'u T; Hunter E; Haubrich R; Mothe B; Edwards A; Riddell L; Chen F; Harrigan PR; Brumme ZL; Mallal S; John M; Jooste JP; Shapiro R; Deeks SG; Walker BD; Brander C; Landis C; Carlson JM; Prado JG; Goulder PJ
J Virol; 2014 May; 88(9):4668-78. PubMed ID: 24501417
[TBL] [Abstract][Full Text] [Related]
40. Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins.
Boutwell CL; Carlson JM; Lin TH; Seese A; Power KA; Peng J; Tang Y; Brumme ZL; Heckerman D; Schneidewind A; Allen TM
J Virol; 2013 Apr; 87(7):3952-65. PubMed ID: 23365420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
